Mark Roeder represents life sciences and technology companies at all stages of their lifecycle, as well as the institutions that finance them. He serves as Global Co-Chair of the Life Sciences Industry Group and previously served as Co-Chair of the Silicon Valley Corporate Department.
Mr. Roeder advises companies on strategic transactions and corporate governance matters. Specifically, he counsels clients on:
- Initial Public Offerings (IPOs)
- Secondary and follow-on equity public offerings
- Strategic buy-side and sell-side mergers and acquisitions
- Venture capital financings
- Convertible debt offerings
He also provides general company representation, advising executives and boards on topics such as:
- Corporate governance matters
- Fiduciary duties
- Securities law compliance
- Executive compensation matters
- Shareholder activism and defense
Mr. Roeder frequently speaks on the IPO process and corporate governance matters.